Cargando…

Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies

INTRODUCTION: Tanezumab is a monoclonal antibody against nerve growth factor that is under investigation for the treatment of osteoarthritis (OA) pain. We conducted subgroup analyses of two randomized phase 3 studies to summarize efficacy, general safety, and adjudicated joint safety of tanezumab in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miki, Kenji, Ohta, Makoto, Abe, Manabu, Yoshimatsu, Hiroki, Fujii, Koichi, Ebata, Nozomi, West, Christine R., Brown, Mark T., Pixton, Glenn, Isogawa, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314481/ https://www.ncbi.nlm.nih.gov/pubmed/35538185 http://dx.doi.org/10.1007/s40122-022-00384-y

Ejemplares similares

General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials
por: Berenbaum, Francis, et al.
Publicado: (2022)

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
por: Berenbaum, Francis, et al.
Publicado: (2021)

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis
por: Birbara, Charles, et al.
Publicado: (2018)

Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
por: Tive, Leslie, et al.
Publicado: (2019)

Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum]
Publicado: (2020)

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study
por: Neogi, Tuhina, et al.
Publicado: (2022)

Relative Efficacy and Safety of Tanezumab for Osteoarthritis: A Systematic Review and Meta-analysis of Randomized-Controlled Trials
por: Zhang, Bocheng, et al.
Publicado: (2021)

First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain
por: Walicke, Patricia A., et al.
Publicado: (2018)

Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
por: Berenbaum, Francis, et al.
Publicado: (2020)

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain
por: Jonsson, E. Niclas, et al.
Publicado: (2016)

Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
por: Schnitzer, Thomas J., et al.
Publicado: (2021)

Clinical Outcomes of Tanezumab With Different Dosages for Patient With Osteoarthritis: Network Meta-Analysis
por: Hu, Rui, et al.
Publicado: (2021)

Safety risk associated with use of nonsteroidal anti‐inflammatory drugs in Japanese elderly compared with younger patients with osteoarthritis and/or chronic low back pain: A retrospective database study
por: Togo, Kanae, et al.
Publicado: (2021)

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab
por: Hunter, D.J., et al.
Publicado: (2022)

Database Analysis on the Relationships Between Nonsteroidal Anti-inflammatory Drug Treatment Variables and Incidence of Acute Myocardial Infarction in Japanese Patients with Osteoarthritis and Chronic Low Back Pain
por: Kikuchi, Shogo, et al.
Publicado: (2021)

Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study
por: Akazawa, Manabu, et al.
Publicado: (2019)

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety
por: Markman, John D., et al.
Publicado: (2020)

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
por: Conaghan, Philip G., et al.
Publicado: (2022)

Tanezumab: Finally a Monoclonal Antibody for Pain Relief
por: Nair, Abhijit S
Publicado: (2018)

Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
por: Patel, Mona K., et al.
Publicado: (2018)

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study
por: Ogura, Yuichiro, et al.
Publicado: (2015)

Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database
por: Ebata-Kogure, Nozomi, et al.
Publicado: (2017)

Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials
por: Berenbaum, Francis, et al.
Publicado: (2021)

Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study
por: Katsuno, Takayuki, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2021)

Response to: “Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis”
por: Tive, Leslie A., et al.
Publicado: (2018)

Effectiveness of pregabalin for treatment of chronic cervical radiculopathy with upper limb radiating pain: an 8-week, multicenter prospective observational study in Japanese primary care settings
por: Taguchi, Toshihiko, et al.
Publicado: (2019)

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo‐controlled phase 3 trial
por: Abe, Masatoshi, et al.
Publicado: (2017)

Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study
por: Narita, Ichiei, et al.
Publicado: (2019)

Use of analgesics before and after total joint replacement in working-age Japanese patients with knee and hip osteoarthritis: A retrospective database study
por: Ebata, Nozomi, et al.
Publicado: (2023)

Tanezumab: a selective humanized mAb for chronic lower back pain
por: Webb, Michael P, et al.
Publicado: (2018)

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON
por: Kudo, Masatoshi, et al.
Publicado: (2016)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study
por: Hashimoto, Shu, et al.
Publicado: (2016)

A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan
por: Akazawa, Manabu, et al.
Publicado: (2019)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]
Publicado: (2017)

Time-Course Evaluation of Body Mass Index in Japanese Children With Obstructive Sleep Apnea Syndrome After Adenotonsillectomy: A Three-Years Follow-Up Study
por: Fukuda, Ken, et al.
Publicado: (2020)

Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
por: Kanda, Yoshinobu, et al.
Publicado: (2022)

Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series
por: Kanda, Yoshinobu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pfon9buijk6uj6t5au7sh5f5dj